Interactions between anturane(sulfinpyrazone) and Coumadin (warfarin)
warfarin and sulfinpyrazone (Major Drug-Drug)
MANAGEMENT: If coumarin derivatives must be used with sulfinpyrazone, the patient should be monitored for excessive anticoagulation. However, it is best to avoid this combination or reduce the anticoagulant dosage by 20% to 50%. Patients should be advised to notify their physician if they experience any signs of excessive anticoagulation, such as unusual or prolonged bleeding, bruising, vomiting, change in stool or urine color, headache, dizziness, or weakness.





